These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18283084)

  • 1. Sensible approaches for reducing clinical trial costs.
    Eisenstein EL; Collins R; Cracknell BS; Podesta O; Reid ED; Sandercock P; Shakhov Y; Terrin ML; Sellers MA; Califf RM; Granger CB; Diaz R
    Clin Trials; 2008; 5(1):75-84. PubMed ID: 18283084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015-2016.
    Qiao Y; Alexander GC; Moore TJ
    Clin Trials; 2019 Jun; 16(3):329-333. PubMed ID: 30922113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the costs of phase III cardiovascular clinical trials.
    Eisenstein EL; Lemons PW; Tardiff BE; Schulman KA; Jolly MK; Califf RM
    Am Heart J; 2005 Mar; 149(3):482-8. PubMed ID: 15864237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.
    Crow RA; Hart KA; McDermott MP; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Hirtz D; Lochmuller H; Straub V; Ciafaloni E; Shieh PB; Spinty S; Childs AM; Manzur AY; Morandi L; Butterfield RJ; Horrocks I; Roper H; Flanigan KM; Kuntz NL; Mah JK; Morrison L; Darras BT; von der Hagen M; Schara U; Wilichowski E; Mongini T; McDonald CM; Vita G; Barohn RJ; Finkel RS; Wicklund M; McMillan HJ; Hughes I; Pegoraro E; Bryan Burnette W; Howard JF; Thangarajh M; Campbell C; Griggs RC; Bushby K; Guglieri M
    Trials; 2018 May; 19(1):291. PubMed ID: 29793540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial management of a large multisite randomized clinical trial.
    Sheffet AJ; Flaxman L; Tom M; Hughes SE; Longbottom ME; Howard VJ; Marler JR; Brott TG;
    Int J Stroke; 2014 Aug; 9(6):811-3. PubMed ID: 24661748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key cost drivers of pharmaceutical clinical trials in the United States.
    Sertkaya A; Wong HH; Jessup A; Beleche T
    Clin Trials; 2016 Apr; 13(2):117-26. PubMed ID: 26908540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of paper-based and electronic data collection process in clinical trials: costs simulation study.
    Pavlović I; Kern T; Miklavcic D
    Contemp Clin Trials; 2009 Jul; 30(4):300-16. PubMed ID: 19345286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013.
    Jeong S; Sohn M; Kim JH; Ko M; Seo HW; Song YK; Choi B; Han N; Na HS; Lee JG; Kim IW; Oh JM; Lee E
    Trials; 2017 Jun; 18(1):288. PubMed ID: 28637515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
    Moore TJ; Zhang H; Anderson G; Alexander GC
    JAMA Intern Med; 2018 Nov; 178(11):1451-1457. PubMed ID: 30264133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conducting non-commercial international clinical trials: the ICR-CTSU experience.
    Fox L; Toms C; Kernaghan S; Snowdon C; Bliss JM
    Trials; 2017 Sep; 18(1):440. PubMed ID: 28950887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE; Majothi S; Heneghan NR; Blissett DB; Riley RD; Sitch AJ; Price MJ; Bates EJ; Turner AM; Bayliss S; Moore D; Singh S; Adab P; Fitzmaurice DA; Jowett S; Jolly K
    Health Technol Assess; 2015 May; 19(36):1-516. PubMed ID: 25980984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.
    Bentley C; Cressman S; van der Hoek K; Arts K; Dancey J; Peacock S
    Clin Trials; 2019 Apr; 16(2):183-193. PubMed ID: 30628466
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.